返回
化工社化工社化学信息打印报告 · 仅供科研参考
HRID 1486466生成日期:2026年10月23日

乙酰胺 → 3,5-二碘-L-甲状腺素

https://huagongshe.com/zh-CN/reaction/1486466

反应方程式

参与物

角色名称HCID投料
反应物乙酰胺HCID 178—
反应物氢溴酸HCID 260—
反应物二甲醚HCID 8254—
反应物碘化氢HCID 24841—
反应物3,5-二碘-4-(4-甲氧苯氧基)-N-乙酰-L-苯丙氨酸乙酯HCID 10952191—
产物3,5-二碘-L-甲状腺素HCID 92859—

反应步骤

Many patent and non-patent literature describe the use of an intermediate called Bis (p-anisyl)iodonium bromide in the preparation of Levothyroxine sodium. Hillmann (Z. Naturforch 1956; 11b:424-425) describes a process for the assembly of the biphenyl-ether system present in Levothyroxine, wherein a key coupling reaction is initiated between N-Acetyl 3,5-diiodo-L-tyrosine ethyl ester, derived from the stepwise protective conversion of amine as amide and acid as ester of 3,5 diido-L-tyrosine, and Bis (p-anisyl)iodonium bromide in the presence of copper metal or powder as a catalyst to afford (S)—N-acetyl-3,5-diiodo-4-p-methoxyphenoxyphenylalanine ethyl ester, with 87% yield. All the three protective groups in (S)—N-acetyl-3,5-diiodo-4-p-methoxyphenoxyphenylalanine ethyl ester, viz. acetamide, methyl ether, ethyl ester were cleaved using a mixture of Hydroiodic acid and Hydrobromic acid to give 3,5-Diiodothyronine. 3,5-Diiodothyronine on subsequent iodination with iodine gave L-thyroxine of an yield that corresponds to 92%.

来源与证据

DOI10.6084/m9.figshare.5104873.v1
专利号US09428444B2
来源数据集uspto-grants-2016_08
ORD IDord-19dc8d269fa84dfbaa970919e8c7f67c
来源说明uspto-grants-2016_08